Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-02

Clinical Trial Update: Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma [NA]

View source ↗

Summary

Clinical trial update on promoting resiliency among lymphoma survivors; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lymphoma | NA | Status: COMPLETED | Results posted: 2019-10-02